Due to poor CMS oversight, the competitive bidding system for mail-ordered diabetes testing systems has reduced patient access to the products, the chief advocacy officer of the American Association of Diabetes Educators said Jan. 23, citing a recent survey put out by the association.
Of the 20 firms selected to participate in the program, none offer a set of brands representing 50 percent of the diabetes testing strips available in spite of a provision...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?